Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter, Pion Pen Distribution Pact for Drug Permeability-analysis Instruments

NEW YORK, Dec. 15 (GenomeWeb News) - Beckman Coulter had entered into a 5-year distribution pact with Pion to deliver instruments for the automation of in vitro drug-permeability instruments.

 

The firms will combine Beckman Coulter's Biomek FX liquid handling system with Pion's double-sink method for parallel artificial membrane permeability analysis. The new instrument, called Biomek FX -ADMETox Workstation, is controlled by software developed by Woburn, Mass.-based Pion.

 

Beckman has validated the automated system and will distribute it worldwide. The firms will collaborate on application-specific customer support and training.

 

Financial terms of the deal were not disclosed.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.